PTH2R
Basic information
Region (hg38): 2:208359714-208854503
Previous symbols: [ "PTHR2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTH2R gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 40 | 44 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 8 | 3 |
Variants in PTH2R
This is a list of pathogenic ClinVar variants found in the PTH2R region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-208407049-C-A | Benign/Likely benign (Nov 01, 2022) | |||
2-208407071-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
2-208407123-G-A | PTH2R-related disorder | Likely benign (Jun 01, 2023) | ||
2-208407126-C-G | PTH2R-related disorder | Likely benign (May 28, 2019) | ||
2-208428205-A-T | not specified | Uncertain significance (Sep 14, 2022) | ||
2-208428217-C-A | not specified | Uncertain significance (Jun 29, 2023) | ||
2-208428225-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
2-208428291-C-G | not specified | Uncertain significance (Apr 07, 2022) | ||
2-208437603-C-A | PTH2R-related disorder | Likely benign (Feb 09, 2021) | ||
2-208437608-G-T | not specified | Uncertain significance (Jan 03, 2024) | ||
2-208437621-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-208437630-A-G | PTH2R-related disorder | Likely benign (Jun 07, 2022) | ||
2-208437787-A-G | not specified | Uncertain significance (Feb 10, 2022) | ||
2-208437788-T-A | PTH2R-related disorder | Uncertain significance (Oct 04, 2023) | ||
2-208437820-A-C | PTH2R-related disorder | Uncertain significance (Dec 23, 2023) | ||
2-208437828-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
2-208437843-T-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-208437849-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
2-208437864-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
2-208442385-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
2-208442425-C-T | Syndromic intellectual disability | Likely pathogenic (Mar 26, 2017) | ||
2-208442442-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
2-208443359-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
2-208443391-G-A | PTH2R-related disorder • not specified | Uncertain significance (Jan 04, 2022) | ||
2-208443420-C-G | not specified | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTH2R | protein_coding | protein_coding | ENST00000272847 | 13 | 494790 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.41e-20 | 0.00138 | 122560 | 30 | 3158 | 125748 | 0.0128 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.774 | 333 | 296 | 1.13 | 0.0000151 | 3604 |
Missense in Polyphen | 128 | 112.77 | 1.135 | 1437 | ||
Synonymous | 0.282 | 105 | 109 | 0.966 | 0.00000587 | 1038 |
Loss of Function | -0.133 | 30 | 29.2 | 1.03 | 0.00000151 | 324 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0131 | 0.0130 |
Ashkenazi Jewish | 0.00873 | 0.00857 |
East Asian | 0.000709 | 0.000707 |
Finnish | 0.00584 | 0.00584 |
European (Non-Finnish) | 0.0214 | 0.0213 |
Middle Eastern | 0.000709 | 0.000707 |
South Asian | 0.00367 | 0.00360 |
Other | 0.0128 | 0.0126 |
dbNSFP
Source:
- Function
- FUNCTION: This is a specific receptor for parathyroid hormone. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. PTH2R may be responsible for PTH effects in a number of physiological systems. It may play a significant role in pancreatic function. PTH2R presence in neurons indicates that it may function as a neurotransmitter receptor (By similarity). {ECO:0000250}.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class B Secretin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.928
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 15.91
Haploinsufficiency Scores
- pHI
- 0.183
- hipred
- N
- hipred_score
- 0.378
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.517
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pth2r
- Phenotype
Gene ontology
- Biological process
- cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;positive regulation of cold-induced thermogenesis
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- parathyroid hormone receptor activity;protein binding;G protein-coupled peptide receptor activity;peptide hormone binding